Published in Breast Cancer Res on December 18, 2009
Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data. BMJ (2011) 0.88
Rational and irrational issues in breast cancer screening. Cancers (Basel) (2011) 0.80
Frank words about breast screening. Open Med (2011) 0.75
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet (1999) 7.72
Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer (2003) 2.26
Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer (1995) 2.01
Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999. Cancer (2000) 1.45
Increase in response rate by prolonged treatment with neoadjuvant letrozole. Breast Cancer Res Treat (2008) 1.01
Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary results. Ann Surg Oncol (2004) 1.01
Molecular markers and therapeutic targets in ductal carcinoma in situ. Microsc Res Tech (2002) 0.91
DCIS and aromatase inhibitors. J Steroid Biochem Mol Biol (2007) 0.87
Histopathology of breast carcinoma following neoadjuvant systemic therapy: a common association between letrozole therapy and central scarring. Histopathology (2007) 0.80